NEW YORK (GenomeWeb News) – Cellular analysis toolmaker Fluxion Biosciences said yesterday that it has hired Bucher Biotec to sell and distribute its research tools to drug developers in Switzerland.
Under the exclusive agreement, Basel-based Bucher will distribute Fluxion’s BioFlux cell imaging analysis tools.
The BioFlux 200 is used in cell adhesion and microbial biofilm studies and allows researchers to study live cells and biofilms under controlled conditions.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.